Core B: International Clinical Core (melioidosis focus)
Official title: Core B: International Clinical Core
Funded at University of Texas Med Br Galveston · NIH-11602459 · Data updated 2026-11-12
A federally funded grant supports international research into melioidosis, a dangerous infection caused by Burkholderia pseudomallei, to improve tests, treatments, and vaccines.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Med Br Galveston NIH-funded |
| Lab location | 1 site (Galveston, United States) |
| Project start | September 1, 2026 |
| Project end | July 31, 2031 |
| Funding year | 2026 |
| Award (this year) | $696,044 |
| NIH project number | 3P01AI199402-01S1 |
| Project ID | NIH-11602459 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are individuals at risk for melioidosis or patients with suspected or confirmed infection, particularly in areas where Burkholderia pseudomallei is present.
✕Less likely to help
People not exposed to or at risk for melioidosis, or those not participating in clinical or translational studies related to this pathogen, may not benefit.
What this research studies
This program brings together researchers from multiple sites to explore how the bacterium and the human body interact in severe lung infections. It aims to uncover why melioidosis becomes so deadly and to translate those findings into better diagnostics, therapies, and vaccines. By studying both the pathogen and host factors, the project seeks tangible advances that can strengthen public health defenses against this high-consequence pathogen. The work is designed to inform clinical care, earlier detection, and development of medical countermeasures for at-risk populations.
Why it matters
Potential benefit: If successful, patients could benefit from earlier diagnosis, more effective treatments, and new vaccines or countermeasures against melioidosis.
How similar studies have gone: Previous research on melioidosis has advanced understanding of its pathogenesis and countermeasures, but effective clinical tools remain an area of active development.
Where this research is happening
-
University of Texas Med Br Galveston
Galveston, United States Active
Researchers
- Principal investigator: Torres, Alfredo G — University of Texas Med Br Galveston
- Study coordinator: Torres, Alfredo G
Related research
Other NIH-funded projects on the same topics.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
West African Center for Emerging Infectious Diseases
A national West African collaboration is studying how dangerous viruses spread between animals and people, with the goal of improving prevention and response.
-
West African Center for Emerging Infectious Diseases
A multi-country program in West Africa aims to better understand how emerging infectious diseases spread from animals to people and how to prevent outbreaks that could affect the U.S.
-
West Africa Center for Emerging Infectious Diseases
A patient-facing center in West Africa studies how emerging viruses spread to people and livestock so we can better protect communities and prevent outbreaks.
-
West African Center for Emerging Infectious Diseases
Aiming to understand and prevent emerging viruses in West Africa to protect people in the U.S. and globally.
-
West Africa Center for Emerging Infectious Diseases
A US-funded center in West Africa aims to better understand and prevent outbreaks of deadly viruses by studying how diseases spread between animals, people, and the environment.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.